FLiRT 2024: New group of Covid variants spreads in US; all you need to know

FLiRT, a group of new Covid variants in the Omicron JN.1 lineage, is spreading in the US. KP.2 and KP 1.1 are more infectious than earlier Omicron variants, which, however, have similar side effects

FLiRT 2024
FLiRT 2024. Photo: Freepik
Sonika Nitin Nimje New Delhi
3 min read Last Updated : May 06 2024 | 4:40 PM IST
FLiRT, a group of new Covid-19 variants from the Omicron JN.1 lineage, is rapidly spreading in the United States, causing concern about a summer infection wave. With new mutations, KP.2 and KP 1.1 variants are deemed to be more contagious than past Omicron variants, however, specialists say the side-effects stay pretty much similar. 
The KP.2 has taken over the JN.1 variant in the country, however, cases of hospitalisations have not surged, according to media reports. KP.1.1, one more FLiRT variant, has been observed in the US, but is not very prevalent compared to KP.2. The nickname 'FLiRT' depends on the technical names for their mutations, as per the Infectious Disease Society of America.

What is FLiRT and what are its symptoms?

Dr Nikhil Modi, Senior Consultant at the Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospital stated, "FLiRT refers to a group of new SARS-CoV-2 variants that have emerged from the Omicron JN.1 lineage and are rapidly spreading across the U.S. The most prominent FLiRT variant is KP.2, which has become the dominant strain in the U.S and accounting for around 25% of new COVID-19 cases as of April 2024".
"The FLiRT variants, especially KP.2, appear to have increased transmissibility compared to previous Omicron sub variants. They also show the ability to evade immunity from prior infection and vaccines, though the extent is still under study. The symptoms associated with FLiRT infection mirror those of other Omicron sub variants, including sore throat, cough, fatigue, nasal congestion, runny nose, headache, muscle aches, fever, and potential loss of taste or smell," Dr Wali further added. 

Do Indians need to panic about the 'FLiRT'?

Dr Modi mentioned that considering individuals in India were not experienced with mRNA vaccines and have acquired immunity broadly through contaminations, there is no reason to panic about a new wave. 
Dr M Wali, Senior Consultant, Department of Medicine, Sir Ganga Ram Hospital, stated, "mRNA vaccines were given routinely in the US and these were associated with impairing the immune function. There were a large group of people who did not take the vaccine and, therefore, they now need to be alert for new variants. In India, that's not the problem. Because the immunity that we acquired was through infections and a large number of people were infected. Our vaccination programme was also huge".

Will Indians get ‘FliRT’ in future?

Dr Modi in his interview said, "While FLiRT has not yet been detected in India, the potential spread of these variants is a significant concern given the country's high population density and varying levels of vaccination and immunity from previous waves".
Dr M Wali said, "New variants will keep coming and we have to keep alert and follow universal precautions like use of masks, keeping social distance, not coughing inappropriately and also have influenza vaccination or flu shot. People above 45 years old and children also can be given flu shots. We have to prepare ourselves for influenza-like illnesses and Covid".
Dr Wali emphasised on updating vaccines, saying future vaccination formulation needs to be aligned with the WHO guidelines, and designed keeping in view the emerging variants like KP 1.1 and so on.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccinecorona

First Published: May 06 2024 | 4:39 PM IST

Next Story